Risk Stratification in Acute Pulmonary Embolism Management
Acute pulmonary embolism (PE) represents a significant cardiovascular emergency, characterized by a high degree of clinical variability and a broad spectrum of outcomes. Effective management hinges on accurate risk stratification, which guides therapeutic decisions and optimizes patient care. This academic overview explores the contemporary approaches to risk stratification in acute PE, highlighting key clinical tools and their role in identifying patients at high risk for adverse events.
The Imperative of Risk Stratification
Risk stratification in acute PE is crucial for several reasons. Firstly, it allows for the identification of patients who are hemodynamically unstable or at high risk of clinical deterioration, necessitating aggressive interventions. Secondly, it helps to distinguish low-risk patients who may be candidates for outpatient management or early discharge, thereby reducing healthcare costs and resource utilization. Finally, it informs the selection of appropriate antithrombotic therapies and the intensity of monitoring required [1].
Clinical Risk Scores: Guiding Initial Assessment
Several validated clinical prediction rules have been developed to assess the short-term mortality risk in patients with acute PE. Among the most widely used are the Pulmonary Embolism Severity Index (PESI) and its simplified version (sPESI).
Pulmonary Embolism Severity Index (PESI)
The PESI score is a comprehensive tool that incorporates 11 clinical variables to predict 30-day mortality in patients with acute PE. These variables include age, sex, history of cancer, chronic heart failure, chronic lung disease, pulse rate, systolic blood pressure, respiratory rate, temperature, mental status, and arterial oxygen saturation. Patients are categorized into five classes (I-V), ranging from very low to very high risk, with corresponding mortality rates [2, 3].
Simplified Pulmonary Embolism Severity Index (sPESI)
Recognizing the complexity of the original PESI, the sPESI was developed as a more practical alternative. It includes six variables: age ≥80 years, history of cancer, chronic cardiopulmonary disease, heart rate ≥110 bpm, systolic blood pressure <100 mmHg, and arterial oxygen saturation <90%. A score of 0 identifies low-risk patients, while a score of ≥1 indicates an increased risk of adverse outcomes [4, 5]. The sPESI has demonstrated comparable prognostic accuracy to the full PESI, making it a valuable tool for rapid risk assessment in the emergency setting.
Hestia Criteria: Facilitating Outpatient Management
For patients deemed low-risk by clinical scores, the Hestia criteria provide a robust framework for identifying those suitable for outpatient treatment. These criteria assess the absence of specific adverse prognostic factors, such as hemodynamic instability, severe hypoxemia, active bleeding, severe renal impairment, and social contraindications to home treatment. Patients meeting all Hestia criteria can often be safely managed outside the hospital, reducing the burden on inpatient resources [6, 7].
Biomarkers and Imaging: Refining Risk Assessment
Beyond clinical scores, biomarkers and imaging modalities play a crucial role in refining risk stratification. Elevated levels of cardiac troponins and B-type natriuretic peptides (BNP) or N-terminal pro-BNP (NT-proBNP) indicate myocardial injury and right ventricular dysfunction, respectively, and are associated with an increased risk of adverse outcomes [1].
Echocardiography and computed tomography pulmonary angiography (CTPA) are essential for assessing right ventricular (RV) function and morphology. RV dysfunction, as evidenced by RV dilation, hypokinesis, or increased RV/LV ratio on imaging, is a strong predictor of adverse outcomes and often necessitates closer monitoring and more aggressive treatment strategies [1, 8].
Conclusion
Risk stratification is an indispensable component of acute PE management. By integrating clinical assessment tools like PESI and sPESI with biomarkers and imaging findings, clinicians can accurately identify patients at varying levels of risk. This comprehensive approach facilitates personalized treatment strategies, optimizes resource allocation, and ultimately improves patient outcomes. It is imperative to remember that this information is for academic purposes and does not constitute medical advice.
References
[1] 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. *JACC*. 2026. [https://www.jacc.org/doi/10.1016/j.jacc.2025.11.005](https://www.jacc.org/doi/10.1016/j.jacc.2025.11.005) [2] Pulmonary Embolism Severity Index (PESI). *MDCalc*. [https://www.mdcalc.com/calc/1304/pulmonary-embolism-severity-index-pesi](https://www.mdcalc.com/calc/1304/pulmonary-embolism-severity-index-pesi) [3] Pulmonary Embolism Severity Index (PESI). *Medscape Reference*. [https://reference.medscape.com/calculator/86/pulmonary-embolism-severity-index-pesi](https://reference.medscape.com/calculator/86/pulmonary-embolism-severity-index-pesi) [4] sPESI (simplified Pulmonary Embolism Severity Index). *QxMD*. [https://qxmd.com/calculate/calculator_777/spesi-simplified-pulmonary-embolism-severity-index](https://qxmd.com/calculate/calculator_777/spesi-simplified-pulmonary-embolism-severity-index) [5] Simplification of the Pulmonary Embolism Severity Index for Risk Stratification in Patients With Acute Pulmonary Embolism. *JAMA Internal Medicine*. 2010. [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/775646](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/775646) [6] Hestia Criteria for Outpatient Pulmonary Embolism Treatment. *MDCalc*. [https://www.mdcalc.com/calc/3918/hestia-criteria-outpatient-pulmonary-embolism-treatment](https://www.mdcalc.com/calc/3918/hestia-criteria-outpatient-pulmonary-embolism-treatment) [7] Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment. *ScienceDirect*. 2013. [https://www.sciencedirect.com/science/article/pii/S1538783622137086](https://www.sciencedirect.com/science/article/pii/S1538783622137086) [8] Risk Stratification in Acute Pulmonary Embolism: Half of the Way.... *AnnalsATS*. [https://www.atsjournals.org/doi/10.1513/AnnalsATS.202005-461RL](https://www.atsjournals.org/doi/10.1513/AnnalsATS.202005-461RL)